Precigen reported a quarterly loss of $0.02 per share, beating the Zacks Consensus Estimate for a $0.03 loss and improving from a $0.07 loss a year ago. The result is a modest earnings upside with year-over-year loss improvement, but the article provides no additional operational or guidance details.
Precigen reported a quarterly loss of $0.02 per share, beating the Zacks Consensus Estimate for a $0.03 loss and improving from a $0.07 loss a year ago. The result is a modest earnings upside with year-over-year loss improvement, but the article provides no additional operational or guidance details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
